• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共同点:1 型糖尿病和乳糜泻的共同风险因素。

Common ground: shared risk factors for type 1 diabetes and celiac disease.

机构信息

Division of Gastroenterology, Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

出版信息

Nat Immunol. 2018 Jul;19(7):685-695. doi: 10.1038/s41590-018-0130-2. Epub 2018 Jun 20.

DOI:10.1038/s41590-018-0130-2
PMID:29925984
Abstract

Risk factors for most autoimmune diseases are multifactorial genetic variants modified by environmental risk factors. Type 1 diabetes and celiac disease share high-risk HLA haplotypes, and the prevalence of both diseases has increased in many regions during the past half century. Unknown environmental factors are suspected to have increased the disease penetrance. Celiac disease depends on immune responses to dietary gluten, whereas the environmental risk factors for type 1 diabetes are not yet clear. Here, we consider the shared heritable genetic factors and review evidence of the dietary and microbial exposures, particularly in early life, that might influence the pathogenesis of one or both diseases. A deeper mechanistic understanding of the environmental factors responsible for increased risk of these diseases should provide opportunities to manipulate exposure in children carrying defined risk markers and thus prevent and attenuate disease, as well as to identify new therapeutic strategies for patients.

摘要

大多数自身免疫性疾病的风险因素是受环境风险因素影响的多因素遗传变异。1 型糖尿病和乳糜泻共享高风险 HLA 单倍型,在过去半个世纪中,许多地区这两种疾病的患病率都有所增加。疑似环境因素增加了疾病的外显率。乳糜泻依赖于对膳食谷蛋白的免疫反应,而 1 型糖尿病的环境风险因素尚不清楚。在这里,我们考虑了共同的遗传因素,并回顾了饮食和微生物暴露的证据,特别是在生命早期,这些因素可能影响一种或两种疾病的发病机制。对导致这些疾病风险增加的环境因素的更深入的机制理解,应该为携带明确风险标志物的儿童提供操纵暴露的机会,从而预防和减轻疾病,并为患者确定新的治疗策略。

相似文献

1
Common ground: shared risk factors for type 1 diabetes and celiac disease.共同点:1 型糖尿病和乳糜泻的共同风险因素。
Nat Immunol. 2018 Jul;19(7):685-695. doi: 10.1038/s41590-018-0130-2. Epub 2018 Jun 20.
2
Type 1 Diabetes Mellitus and Celiac Disease: Distinct Autoimmune Disorders That Share Common Pathogenic Mechanisms.1 型糖尿病和乳糜泻:具有共同发病机制的两种不同自身免疫性疾病。
Horm Res Paediatr. 2019;92(5):285-292. doi: 10.1159/000503142. Epub 2019 Oct 8.
3
The Role of Gluten in Celiac Disease and Type 1 Diabetes.麸质在乳糜泻和1型糖尿病中的作用。
Nutrients. 2015 Aug 26;7(9):7143-62. doi: 10.3390/nu7095329.
4
Molecular mechanisms of HLA association with autoimmune diseases.HLA与自身免疫性疾病关联的分子机制。
Tissue Antigens. 2009 Jan;73(1):1-8. doi: 10.1111/j.1399-0039.2008.01167.x. Epub 2008 Nov 10.
5
Coeliac disease and insulin-dependent diabetes mellitus: a causal association?乳糜泻与胰岛素依赖型糖尿病:存在因果关联吗?
Acta Paediatr. 1995 Dec;84(12):1432-3. doi: 10.1111/j.1651-2227.1995.tb13583.x.
6
An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland.在爱尔兰西部各郡进行的一项针对易患乳糜泻基因的常染色体筛查。
Nat Genet. 1996 Nov;14(3):329-33. doi: 10.1038/ng1196-329.
7
Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.乳糜泻和非乳糜泻麸质敏感的免疫遗传学发病机制
Curr Gastroenterol Rep. 2016 Jul;18(7):36. doi: 10.1007/s11894-016-0512-2.
8
Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity.1型糖尿病与乳糜泻自身免疫的遗传背景对比
Diabetes Care. 2015 Oct;38 Suppl 2(Suppl 2):S37-44. doi: 10.2337/dcs15-2007.
9
Celiac disease and autoimmunity.乳糜泻与自身免疫
J Pediatr Gastroenterol Nutr. 2014 Jul;59 Suppl 1:S9-S11. doi: 10.1097/01.mpg.0000450394.30780.ea.
10
[Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].[1型糖尿病特异性自身抗体的患病率以及乳糜泻中某些HLA模式的患病率]
Dtsch Med Wochenschr. 2003 Jan 31;128(5):185-9. doi: 10.1055/s-2003-36982.

引用本文的文献

1
Children With Celiac Disease Have a Higher Degree of Activated or Exhausted CD4 and CD8 T Cells Compared to Healthy References.与健康对照相比,患有乳糜泻的儿童具有更高程度的活化或耗竭的CD4和CD8 T细胞。
Scand J Immunol. 2025 Sep;102(3):e70054. doi: 10.1111/sji.70054.
2
The Implications of Type 1 Diabetes Mellitus Associated with Coeliac Disease.1型糖尿病与乳糜泻相关性的影响
J Clin Med. 2025 Jul 18;14(14):5129. doi: 10.3390/jcm14145129.
3
Can the Regime Type (Democracy versus Autocracy) Explain the COVID-19 Recovery Rates?政体类型(民主制与专制制)能解释新冠疫情的恢复率吗?
Chin Polit Sci Rev. 2022 Jun 9:1-19. doi: 10.1007/s41111-022-00218-4.
4
Pancreatic Comorbidities in Pediatric Celiac Disease: Exocrine Pancreatic Insufficiency, Pancreatitis, and Diabetes Mellitus.小儿乳糜泻的胰腺合并症:外分泌性胰腺功能不全、胰腺炎和糖尿病
Diagnostics (Basel). 2025 May 14;15(10):1243. doi: 10.3390/diagnostics15101243.
5
Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂(SGLT2Is)-TLRs 轴调节糖尿病。
Cell Biochem Biophys. 2023 Dec;81(4):599-613. doi: 10.1007/s12013-023-01164-x. Epub 2023 Sep 1.
6
Gut microbiota: A magical multifunctional target regulated by medicine food homology species.肠道微生物群:一种受药食同源物种调节的神奇多功能靶标。
J Adv Res. 2023 Oct;52:151-170. doi: 10.1016/j.jare.2023.05.011. Epub 2023 Jun 2.
7
HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus.HLA DQ2/DQ8 单体型和抗转谷氨酰胺酶抗体作为 1 型糖尿病患儿的乳糜泻标志物。
Arch Endocrinol Metab. 2022 Apr 28;66(2):229-236. doi: 10.20945/2359-3997000000457. Epub 2022 Apr 11.
8
Integrating Oral, Physical, and Mental Health Via Public Health Literacy.通过公共卫生素养整合口腔、身体和心理健康。
Health Lit Res Pract. 2022 Jan;6(1):e17-e24. doi: 10.3928/24748307-20220105-01. Epub 2022 Feb 4.
9
Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease.乳糜泻研究学会关于乳糜泻空白和机遇的立场声明。
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):875-884. doi: 10.1038/s41575-021-00511-8. Epub 2021 Sep 15.
10
Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases.硼替佐米:一种用于治疗自身免疫性疾病的蛋白酶体抑制剂。
Inflammopharmacology. 2021 Oct;29(5):1291-1306. doi: 10.1007/s10787-021-00863-2. Epub 2021 Aug 23.